INCYTE CORP Quarterly Costs and Expenses in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Incyte Corp quarterly/annual Costs and Expenses history and growth rate from Q1 2010 to Q3 2024.
  • Incyte Corp Costs and Expenses for the quarter ending September 30, 2024 was $992M, a 40.8% increase year-over-year.
  • Incyte Corp Costs and Expenses for the twelve months ending September 30, 2024 was $4.13B, a 32.9% increase year-over-year.
  • Incyte Corp annual Costs and Expenses for 2023 was $3.08B, a 9.23% increase from 2022.
  • Incyte Corp annual Costs and Expenses for 2022 was $2.82B, a 17.3% increase from 2021.
  • Incyte Corp annual Costs and Expenses for 2021 was $2.4B, a 18.1% decline from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $4.13B $992M +$287M +40.8% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-29
Q2 2024 $3.84B $1.52B +$761M +100% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-30
Q1 2024 $3.08B $789M +$5.09M +0.65% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-30
Q4 2023 $3.08B $826M -$30.5M -3.57% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-13
Q3 2023 $3.11B $704M +$19.4M +2.83% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-29
Q2 2023 $3.09B $761M +$104M +15.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-30
Q1 2023 $2.98B $784M +$167M +27.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-30
Q4 2022 $2.82B $857M +$104M +13.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-13
Q3 2022 $2.71B $685M +$107M +18.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-31
Q2 2022 $2.6B $657M +$92.1M +16.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-01
Q1 2022 $2.51B $617M +$111M +21.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-02
Q4 2021 $2.4B $752M +$127M +20.3% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-13
Q3 2021 $2.27B $578M -$37.7M -6.13% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-01
Q2 2021 $2.31B $565M +$108M +23.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 $2.2B $506M -$727M -59% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q4 2020 $2.93B $625M +$141M +29.1% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-07
Q3 2020 $2.79B $615M +$198M +47.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 $2.59B $457M +$26M +6.02% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 $2.57B $1.23B +$809M +191% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 $1.76B $484M +$38M +8.5% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-08
Q3 2019 $1.72B $417M -$1.3M -0.31% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $1.72B $431M -$6.96M -1.59% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-04
Q1 2019 $1.73B $424M -$25.6M -5.7% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-05
Q4 2018 $1.75B $446M -$130M -22.6% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-09
Q3 2018 $1.88B $419M +$52M +14.2% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-30
Q2 2018 $1.83B $438M +$119M +37.3% Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-30
Q1 2018 $1.71B $449M -$67.9M -13.1% Jan 1, 2018 Mar 31, 2018 10-Q 2019-04-30
Q4 2017 $1.78B $577M +$292M +103% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-13
Q3 2017 $1.49B $367M +$119M +48.3% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-30
Q2 2017 $1.37B $319M +$117M +58.2% Apr 1, 2017 Jun 30, 2017 10-Q 2018-07-31
Q1 2017 $1.25B $517M +$290M +127% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-01
Q4 2016 $961M $284M +$106M +59.1% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-14
Q3 2016 $855M $247M +$59.5M +31.7% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-31
Q2 2016 $796M $202M +$31.3M +18.4% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-01
Q1 2016 $764M $227M +$61.2M +36.8% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q4 2015 $703M $179M +$29.2M +19.5% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-15
Q3 2015 $674M $188M +$59.5M +46.4% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-01
Q2 2015 $614M $170M +$44.6M +35.5% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 $570M $166M +$53.5M +47.4% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 $516M $150M +$36.4M +32.1% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-14
Q3 2014 $480M $128M +$29.9M +30.4% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-03
Q2 2014 $450M $126M +$41.4M +49.1% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-04
Q1 2014 $409M $113M +$37.6M +50% Jan 1, 2014 Mar 31, 2014 10-Q 2015-04-30
Q4 2013 $371M $113M +$29.6M +35.4% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-12
Q3 2013 $341M $98.3M +$27.7M +39.2% Jul 1, 2013 Sep 30, 2013 10-Q 2014-10-30
Q2 2013 $314M $84.4M +$13M +18.3% Apr 1, 2013 Jun 30, 2013 10-Q 2014-07-31
Q1 2013 $301M $75.2M +$4.81M +6.83% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-01
Q4 2012 $296M $83.6M +$10.6M +14.5% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-17
Q3 2012 $285M $70.6M +$11.7M +19.9% Jul 1, 2012 Sep 30, 2012 10-Q 2013-10-31
Q2 2012 $274M $71.3M +$13.4M +23.1% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-01
Q1 2012 $260M $70.4M +$22.6M +47.2% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-02
Q4 2011 $238M $73M +$29.5M +67.7% Oct 1, 2011 Dec 31, 2011 10-K 2014-02-21
Q3 2011 $208M $58.9M +$20M +51.3% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-01
Q2 2011 $188M $57.9M +$21.7M +59.9% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-03
Q1 2011 $167M $47.8M +$10.7M +28.8% Jan 1, 2011 Mar 31, 2011 10-Q 2012-04-26
Q4 2010 $156M $43.6M Oct 1, 2010 Dec 31, 2010 10-K 2013-02-21
Q3 2010 $38.9M Jul 1, 2010 Sep 30, 2010 10-Q 2011-10-27
Q2 2010 $36.2M Apr 1, 2010 Jun 30, 2010 10-Q 2011-07-28
Q1 2010 $37.1M Jan 1, 2010 Mar 31, 2010 10-Q 2011-05-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.